Skip to main content
رجوع
OLMA logo

Olema Pharmaceuticals, Inc.

جودة البيانات: 100%
ذروة بيع
OLMA
NASDAQ Healthcare Biotechnology
KWD 13.97
▼ KWD 0.11 (-0.78%)
القيمة السوقية: 1.22B
نطاق اليوم
KWD 13.93 KWD 14.91
نطاق 52 أسبوعًا
KWD 2.86 KWD 36.26
حجم التداول
1,384,355
متوسط 50 يوم / 200 يوم
KWD 23.15 / KWD 14.30
الإغلاق السابق
KWD 14.08

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -7.5 0.4
P/B 2.5 2.9
ROE % -36.6 3.7
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 42.500 +204.2%
Low: KWD 38.000 High: KWD 48.000
ربحية السهم المستقبلية
-KWD 2.240
الإيرادات المقدّرة
2.3 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.578
KWD 0.211 – KWD 1.029
550 M 2
FY2029 -KWD 0.943
-KWD 1.679 – -KWD 0.344
300 M 2
FY2028 -KWD 1.929
-KWD 3.384 – -KWD 0.561
130 M 4

النقاط الرئيسية

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -146.72M
PEG of 0.89 suggests growth is underpriced

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-36.61%
ROIC-27.94%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.00
Current Ratio9.95
Interest Coverage0.00

التقييم

P/E Ratio
-7.50
P/B Ratio2.54
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -162.45M
ROE -36.61% ROA -30.45%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -146.72M
ROIC -27.94% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 9.95
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -7.50 P/B Ratio 2.54
P/S Ratio N/A PEG Ratio 0.89
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.22B Enterprise Value 1.17B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -162.45M -129.47M -96.66M -104.79M -71.10M
EPS (Diluted) -1.87 -2.20 -2.14 -2.62 -1.79
Gross Profit 0.0 0.0 0.0 0.0 0.0
Operating Income -178.70M -142.26M -104.96M -106.99M -71.49M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 533.43M 450.98M 276.95M 215.65M 295.95M
Total Liabilities 54.87M 42.02M 23.05M 18.10M 11.38M
Shareholders' Equity 478.56M 408.96M 253.90M 197.55M 284.57M
Total Debt 1.19M 1.43M 2.42M 2.57M 3.29M
Cash & Equivalents 48.30M 139.48M 68.54M 23.70M 13.81M
Current Assets 515.45M 438.47M 266.51M 208.90M 290.69M
Current Liabilities 51.80M 41.76M 21.62M 16.55M 9.02M